All Stories

  1. Cerebrospinal fluid brevican and neurocan fragment patterns in human traumatic brain injury
  2. Current and emerging disease modulatory therapies and treatment targets for multiple sclerosis
  3. Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus
  4. Infections in patients with multiple sclerosis: A national cohort study in Sweden
  5. Gsta4 controls apoptosis of differentiating adult oligodendrocytes during homeostasis and remyelination via the mitochondria-associated Fas-Casp8-Bid-axis
  6. Gsta4 controls apoptosis of differentiating adult oligodendrocytes during homeostasis and remyelination via the mitochondria-associated Fas/Casp8/Bid-axis
  7. Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity
  8. Retinal nerve fiber layer thickness associates with cognitive impairment and physical disability in multiple sclerosis
  9. Rituximab treatment for multiple sclerosis
  10. Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression
  11. Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis – Yes
  12. Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis
  13. Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
  14. MicroRNAs as promising novel biomarkers and potential drug targets for inflammatory neurological diseases
  15. P300 amplitude and response speed relate to preserved cognitive function in relapsing–remitting multiple sclerosis
  16. Risk factors for amyotrophic lateral sclerosis
  17. Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
  18. High Glutathione-S-transferase 4 alpha expression promotes nerve cell survival in neurodegenerative disorders
  19. Genetic study of Pandemrix-associated narcolepsy
  20. Methylome characterization of CD4+ T cells in multiple sclerosis — Establishing a role for miR-21 in autoimmune disease
  21. Phenotypes and Predictors of Pain Following Traumatic Spinal Cord Injury: A Prospective Study
  22. Variability in C-Type Lectin Receptors Regulates Neuropathic Pain-Like Behavior after Peripheral Nerve Injury
  23. Regulated Extracellular Choline Acetyltransferase Activity— The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway
  24. Genetic variability in the rat Aplec C-type lectin gene cluster regulates lymphocyte trafficking and motor neuron survival after traumatic nerve root injury
  25. Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
  26. Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
  27. Naturally Occurring Variation in the Glutathione-S-Transferase 4 Gene Determines Neurodegeneration After Traumatic Brain Injury
  28. Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
  29. The DQB1*03:02 HLA haplotype is associated with increased risk of chronic pain after inguinal hernia surgery and lumbar disc herniation
  30. Strain influences on inflammatory pathway activation, cell infiltration and complement cascade after traumatic brain injury in the rat
  31. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106
  32. The Calcitonin Receptor Gene Is a Candidate for Regulation of Susceptibility to Herpes simplex Type 1 Neuronal Infection Leading to Encephalitis in Rat
  33. Unmet medical needs with current standard treatments
  34. iNOS-mediated secondary inflammatory response differs between rat strains following experimental brain contusion
  35. Naturally Occurring Genetic Variability in Expression of Gsta4 is Associated with Differential Survival of Axotomized Rat Motoneurons
  36. Concomitant autoimmunity in myasthenia gravis — Lack of association with IgA deficiency
  37. Both MHC and non-MHC genes regulate inflammation and T-cell response after traumatic brain injury
  38. The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis
  39. Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
  40. Influence of Perineurial Cells and Toll-Like Receptors 2 and 9 on Herpes simplex Type 1 Entry to the Central Nervous System in Rat Encephalitis
  41. Genetic regulation of microglia activation, complement expression, and neurodegeneration in a rat model of traumatic brain injury
  42. Swedish natalizumab (Tysabri) multiple sclerosis surveillance study
  43. Genetic aspects in TBI
  44. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta
  45. Identification of gene regions regulating inflammatory microglial response in the rat CNS after nerve injury
  46. Fine Mapping of Gene Regions Regulating Neurodegeneration
  47. Both MHC and non-MHC genes regulate development of experimental neuropathic pain in rats
  48. Genetic analysis of neuropathic pain-like behavior following peripheral nerve injury suggests a role of the major histocompatibility complex in development of allodynia
  49. Host strain-dependent difference in susceptibility in a rat model of herpes simplex type 1 encephalitis
  50. The axon reaction: Identifying the genes that make a difference
  51. Recovery from spinal cord injury differs between rat strains in a major histocompatibility complex-independent manner
  52. Genetics of autoimmune neuroinflammation
  53. Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes
  54. Differential Expression of the Chemokine Receptors CX3CR1 and CCR1 by Microglia and Macrophages in Myelin-Oligodendrocyte-Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis
  55. Genetic Regulation of Nerve Avulsion-Induced Spinal Cord Inflammation
  56. Inflammation and neurodegeneration
  57. Expression of T cell immunoglobulin- and mucin-domain-containing molecules-1 and -3 (TIM-1 and -3) in the rat nervous and immune systems
  58. Genetic dissection of neurodegeneration and CNS inflammation
  59. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction
  60. Prior poliomyelitis—IvIg treatment reduces proinflammatory cytokine production
  61. Facial nerve lesion response; strain differences but no involvement of IFN-γ, STAT4 or STAT6
  62. Differential expression of multiple alternative spliceforms of the Men1 tumor suppressor gene in mouse
  63. Neuroinflammation in the rat - CNS cells and their role in the regulation of immune reactions
  64. Menin Interacts Directly with the Homeobox-Containing Protein Pem
  65. Neurodegeneration and glial activation patterns after mechanical nerve injury are differentially regulated by non‐MHC genes in congenic inbred rat strains
  66. Neurodegeneration and glial activation patterns after mechanical nerve injury are differentially regulated by non-MHC genes in congenic inbred rat strains
  67. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration
  68. Molecular characterization of human and murine C11orf5, a new member of the FAUNA gene cluster
  69. Differential regulation of trophic factor receptor mRNAs in spinal motoneurons after sciatic nerve transection and ventral root avulsion in the rat
  70. Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis
  71. Regulation of laminin-associated integrin subunit mRNAs in rat spinal motoneurons during postnatal development and after axonal injury
  72. Expression of nonclassical MHC class I (RT1-U) in certain neuronal populations of the central nervous system
  73. Expression of MHC class I heavy chain and β2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons
  74. Non-MHC gene regulation of nerve root injury induced spinal cord inflammation and neuron death
  75. Restricted Expression Pattern ofvegf-din the Adult and Fetal Mouse: High Expression in the Embryonic Lung
  76. Expression of insulin-like growth factors and corresponding binding proteins (IGFBP 1-6) in rat spinal cord and peripheral nerve after axonal injuries
  77. Expression of insulin‐like growth factors and corresponding binding proteins (IGFBP 1–6) in rat spinal cord and peripheral nerve after axonal injuries
  78. Characterization of the mouse Men1 gene and its expression during development
  79. Characterization of the human synaptogyrin gene family
  80. Expression and chromosomal localization of the Requiem gene
  81. Expression of theBCL6Gene in the Pre- and Postnatal Mouse
  82. A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse
  83. Mapping of the human Ca2+ channel β4 subunit to 2q22-23 and its expression in developing mouse
  84. VAMP‐1 and VAMP‐2 gene expression in rat spinal motoneurones: differential regulation after neuronal injury
  85. Sequence and Expression of the Mouse Homologue to Human Phospholipase C β3 Neighboring Gene
  86. Differential subcellular localization of SNAP-25a and SNAP-25b RNA transcripts in spinal motoneurons and plasticity in expression after nerve injury
  87. Expression of the VEGF-Related Factor Gene in Pre- and Postnatal Mouse
  88. Expression of the phosphoinositide-specific phospholipase Cβ3 gene in the rat
  89. Expression of NMDA Receptor mRNAs in Rat Motoneurons is Down-regulated after Axotomy
  90. Increase in α-CGRP and GAP-43 in aged motoneurons: A study of peptides, growth factors, and ChAT mRNA in the lumbar spinal cord of senescent rats with symptoms of hindlimb incapacities
  91. Fibroblast Growth Factors Regulate Calcitonin Gene-related Peptide mRNA Expression in Rat Motoneurons after Lesion and in Culture
  92. Adhesive/Repulsive Properties in the Injured Spinal Cord: Relation to Myelin Phagocytosis by Invading Macrophages
  93. Increased trkB mRNA expression by axotomized motoneurones
  94. trkC-like Immunoreactivity in the Primate Descending Serotoninergic System
  95. The peptidergic motoneurone
  96. Calcitonin Gene-Related Peptide in the Brain, Spinal Cord, and Some Peripheral Systems
  97. Calcitonin Gene-related Peptide (CGRP)-like Immunoreactivity and CGRP mRNA in Rat Spinal Cord Motoneurons after Different Types of Lesions